Adiponectin Testing Market Size, Share, and Trends Analysis Report
CAGR :
| Market Size 2023 (Base Year) | USD 2.27 Billion |
| Market Size 2032 (Forecast Year) | USD 4.59 Billion |
| CAGR | 8.14% |
| Forecast Period | 2024 - 2032 |
| Historical Period | 2018 - 2023 |
Adiponectin Testing Market Insights
A latest report by Market Research Store estimates that the Global Adiponectin Testing Market was valued at USD 2.27 Billion in 2023 and is expected to reach USD 4.59 Billion by 2032, with a CAGR of 8.14% during the forecast period 2024-2032. The report Adiponectin Testing Market overview, growth factors, restraints, opportunities, segmentation, key developments, competitive landscape, consumer insights, and market growth forecast in terms of value or volume. These structured details offer an all-inclusive market overview, providing valuable insights for investment decisions, business decisions, strategic planning, and competitive analysis.
Adiponectin Testing Market: Report Scope
| Report Attributes | Report Details |
|---|---|
| Report Name | Adiponectin Testing Market |
| Market Size in 2023 | USD 2.27 Billion |
| Market Forecast in 2032 | USD 4.59 Billion |
| Growth Rate | CAGR of 8.14% |
| Number of Pages | 197 |
| Key Companies Covered | Stratec SE, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, Eagle Biosciences, Boster Biological Technology, and LabCorp. |
| Segments Covered | By Product Type, By Application, And By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2023 |
| Forecast Year | 2024 to 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
According to the report published by the Market Research Store, global demand for the adiponectin testing market was estimated at approximately USD 1,905.2 Million in 2020 and is expected to generate revenue of around USD 2,600.6 Million by end of 2026, growing at a CAGR of around 5.6% between 2021 and 2026.
Global Adiponectin Testing Market: Overview
Adiponectin has shown significant clinical potential as an adipocyte-derived protein in the pathophysiology of metabolic diseases and coronary artery disease. A higher level of circulating adiponectin is associated with a high risk of pre-diabetes, metabolic syndrome, and adverse cardiovascular events. Numerous studies completed on animal models have highlighted these findings, a key evolutionary factor for the adiponectin testing market. Moreover, the health care industry has also focused on profiting from the testing on animals where insulin-sensitizing, antiatherogenic, anti-inflammatory, cardiomyocyte-protective properties of the hormone are utilized.
Over the last few decades, considerable efforts have been made in searching for the use of adiponectin testing as a potential biomarker in insulin sensitivity and obesity in human patients. Still, the test isn’t considered a key determinant in positively identifying metabolic disease risks in patients. The key application areas of adiponectin testing are for diagnostics and research. The methods used consist of enzyme-linked immunosorbent assay (ELISA) and enzyme immunoassay kits.
| REPORT SNAPSHOT & REPORTING DATA TIMEFRAME | |
|---|---|
| Parameter | Details |
| Historical Date ( Actual Data) | 2016 - 2020 |
| Base Year Data | 2020 |
| Current Year Data | 2021 |
| Projected Data | 2021 - 2026 |
The drive for the adiponectin testing market stems from the increasing potential of adipose-derived products as a drug target for treating as well as preventing cardio metabolic diseases. The latest prospects have appeared in the market from the growing body of research on understanding the pathophysiology of metabolic syndrome. This syndrome has evoked severe concern in the healthcare systems across the world. The marked mortality rate of diseases caused by this syndrome, such as cardiovascular disease (CVD), type 2diabetes, and non-alcoholic fatty liver disease (NAFLD) has expanded the range of the adiponectin testing market.
Global Adiponectin Testing Market: Growth Factor
In recent years, drug manufacturers have been focusing on new drug targets for insulin resistance (IR)-related metabolic disorders, which is driving the industry interest in adiponectin testing. However, the rising demand for the population for the diagnosis of hypoadiponectinemia has boosted the possibility of the adiponectin testing market. Furthermore, the increasing epidemic of obese populations of all ages has also been stimulating the clinical studies on adiponectin levels in the body. Also, adiponectin testing has been rising in the use for livestock.
Manufacturers of testing kits are determined to increase their product portfolio in the adiponectin testing market, and several have entered into the latest product launches and acquisitions. They have also garnered scientific backing based on a meta-analysis of the clinical potential of adiponectin. Moreover, they have been obtaining from the epidemiology survey with the aim of sustaining the diagnostic potential of products in the adiponectin testing market.
The introduction of functional food ingredients that claim to progress adipocyte health and adiponectin metabolism has increased the opportunities for market players. Throughout the years, studies that focus on the meta-analysis of the hormone as a biomarker for the diagnosis of metabolic syndrome have gained steam, thus enhancing the adiponectin testing market. The newest development and advancement in laboratory infrastructure for such tests have driven investment in the adiponectin testing market.
Global Adiponectin Testing Market: Segmentation
The global adiponectin testing market is classifying on the basis of product type, and application. Based on the type, the market is divided into ELISA testing, enzyme immunoassay testing, and others. In terms of application, the adiponectin testing market is segmented into the hospital, specialty clinics, diagnostics laboratories, and others.
Global Adiponectin Testing Market: Regional Analysis
The adiponectin testing market has been witnessing sizable avenues in the regions of North America, Europe, Latin America, Oceania, Asia, and the Middle East and Africa. In terms of region, North America has been contributing the largest share of growth to the global adiponectin testing market. The development can be apportioned to the growing potential of adipose-based products in reinforcing the drug pipelines for treating metabolic syndrome. Also, Asia-Pacific countries with the expanding medical tourism have been showing great potential in the adiponectin testing market.
Global Adiponectin Testing Market: Competitive Players
Some major players in the global adiponectin testing market are Stratec SE, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, Eagle Biosciences, Boster Biological Technology, and LabCorp.
For example, Laboratory Corporation of America Holdings, more commonly known as Labcorp operates one of the largest clinical laboratory networks in the world, with a United States network of 36 primary laboratories. In March 2020, Labcorp received emergency use authorization from the FDA for a test for 2019-nCov to help mitigate the COVID-19 pandemic. And it is one of the six large commercial lab companies that are conducting most of the United States' coronavirus testing along with ARUP, BioReference Laboratories, Mayo Clinic, Quest Diagnostics, and Sonic Healthcare.
Global Adiponectin Testing Market: By Type
- ELISA Testing
- Enzyme Immunoassay Testing
- Others
Global Adiponectin Testing Market: By Application
- Hospital
- Specialty Clinics
- Diagnostics Laboratories
- Others
Global Adiponectin Testing Market: Regional Segmentation Analysis
- North America
- U.S.
- Canada
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Frequently Asked Questions
What are the key factors driving global adiponectin testing market expansion?
The drug manufacturers have been focusing on new drug targets for insulin resistance (IR)-related metabolic disorders, which is driving the industry interest in adiponectin testing. Also, the rising demand for the population for the diagnosis of hypoadiponectinemia has boosted the possibility of the adiponectin testing market.
What will be the value of the adiponectin testing market during 2021- 2026?
The global demand for the adiponectin testing market was estimated at approximately USD 1,905.2 Million in 2020 and is expected to generate revenue of around USD 2,600.6 Million by end of 2026, growing at a CAGR of around 5.6% between 2021 and 2026.
Which region will make notable contributions towards global adiponectin testing market revenue?
In terms of region, North America has been contributing the largest share of growth to the global adiponectin testing market.
What are the key players leveraging adiponectin testing market growth?
Some major players in the global adiponectin testing market are Stratec SE, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, Eagle Biosciences, Boster Biological Technology, and LabCorp.
Frequently Asked Questions
These dominant industry players use well planned strategies to occupied highest market share in this market. Some of the top players in [Keyword] business includes. [Company list]
As per [Keyword] market analysis, North America is forecasted to occupied major share in the [Keyword] market.
The statistical data of the dominant industry player of [Keyword] market can be acquired from the company profile segment described in the report. This segment come up with analysis of major player’s in the [Keyword] market, also their last five-year revenue, segmental, product offerings, key strategies adopted and geographical revenue produced.
The report come up with a segment of the [Keyword] market based on Type, Region, and Application, Also offer a determined view on the [Keyword] market.
The report offers a nitty-gritty estimation of the market by providing data on various viewpoints that incorporate, restraints, drivers, and opportunities threats. This data can help in making suitable decisions for stakeholders before investing.
The sample report for [Keyword] market can be received after the apply from the website.
Table Of Content
- Chapter 1 Executive Summary
- 1.1. Introduction of Adiponectin Testing
- 1.2. Global Adiponectin TestingMarket, 2020 & 2026 (USD Million)
- 1.3. Global Adiponectin Testing Market, 2016 – 2026(USD Million)
- 1.4. Global Adiponectin Testing Market Absulute Revenue Opportunity, 2016 – 2026(USD Million)
- 1.5. Global Adiponectin Testing MarketIncremental Revenue Opportunity, 2020 – 2026(USD Million)
- Chapter 2 Adiponectin TestingMarket – Type Analysis
- 2.1. Global Adiponectin Testing Market – Type Overview
- 2.2. Global Adiponectin Testing Market Share, by Type, 2020 & 2026(USD Million)
- 2.3. ELISA Testing
- 2.3.1. Global ELISA TestingAdiponectin Testing Market, 2016 – 2026(USD Million)
- 2.4. Enzyme Immunoassay Testing
- 2.4.1. Global Enzyme Immunoassay TestingAdiponectin Testing Market, 2016 – 2026(USD Million)
- 2.5. Others
- 2.5.1. Global OthersAdiponectin Testing Market, 2016 – 2026(USD Million)
- Chapter 3 Adiponectin TestingMarket – Application Analysis
- 3.1. Global Adiponectin Testing Market – Application Overview
- 3.2. Global Adiponectin Testing Market Share, by Application, 2020 & 2026(USD Million)
- 3.3. Hospital
- 3.3.1. Global HospitalAdiponectin Testing Market, 2016 – 2026(USD Million)
- 3.4. Specialty Clinics
- 3.4.1. Global Specialty ClinicsAdiponectin Testing Market, 2016 – 2026(USD Million)
- 3.5. Diagnostics Laboratories
- 3.5.1. Global Diagnostics LaboratoriesAdiponectin Testing Market, 2016 – 2026(USD Million)
- 3.6. Others
- 3.6.1. Global OthersAdiponectin Testing Market, 2016 – 2026(USD Million)
- Chapter 4 Adiponectin TestingMarket – Regional Analysis
- 4.1. Global Adiponectin Testing Market Regional Overview
- 4.2. Global Adiponectin Testing Market Share, by Region, 2020 & 2026(USD Million)
- 4.3. North America
- 4.3.1. North AmericaAdiponectin Testing Market, 2016 – 2026(USD Million)
- 4.3.1.1. North AmericaAdiponectin Testing Market, by Country, 2016 - 2026(USD Million)
- 4.3.2. North AmericaAdiponectin Testing Market, by Type, 2016 – 2026
- 4.3.2.1. North AmericaAdiponectin Testing Market, by Type, 2016 – 2026(USD Million)
- 4.3.3. North AmericaAdiponectin Testing Market, by Application, 2016 – 2026
- 4.3.3.1. North AmericaAdiponectin Testing Market, by Application, 2016 – 2026(USD Million)
- 4.3.4. U.S.
- 4.3.4.1. U.S.Adiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.3.5. Canada
- 4.3.5.1. CanadaAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.3.1. North AmericaAdiponectin Testing Market, 2016 – 2026(USD Million)
- 4.4. Europe
- 4.4.1. EuropeAdiponectin Testing Market, 2016 – 2026(USD Million)
- 4.4.1.1. EuropeAdiponectin Testing Market, by Country, 2016 - 2026(USD Million)
- 4.4.2. EuropeAdiponectin Testing Market, by Type, 2016 – 2026
- 4.4.2.1. EuropeAdiponectin Testing Market, by Type, 2016 – 2026(USD Million)
- 4.4.3. EuropeAdiponectin Testing Market, by Application, 2016 – 2026
- 4.4.3.1. EuropeAdiponectin Testing Market, by Application, 2016 – 2026(USD Million)
- 4.4.4. Germany
- 4.4.4.1. GermanyAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.4.5. France
- 4.4.5.1. FranceAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.4.6. U.K.
- 4.4.6.1. U.K.Adiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.4.7. Italy
- 4.4.7.1. ItalyAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.4.8. Spain
- 4.4.8.1. SpainAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.4.9. Rest of Europe
- 4.4.9.1. Rest of EuropeAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.4.1. EuropeAdiponectin Testing Market, 2016 – 2026(USD Million)
- 4.5. Asia Pacific
- 4.5.1. Asia PacificAdiponectin Testing Market, 2016 – 2026(USD Million)
- 4.5.1.1. Asia PacificAdiponectin Testing Market, by Country, 2016 - 2026(USD Million)
- 4.5.2. Asia PacificAdiponectin Testing Market, by Type, 2016 – 2026
- 4.5.2.1. Asia PacificAdiponectin Testing Market, by Type, 2016 – 2026(USD Million)
- 4.5.3. Asia PacificAdiponectin Testing Market, by Application, 2016 – 2026
- 4.5.3.1. Asia PacificAdiponectin Testing Market, by Application, 2016 – 2026(USD Million)
- 4.5.4. China
- 4.5.4.1. ChinaAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.5.5. Japan
- 4.5.5.1. JapanAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.5.6. India
- 4.5.6.1. IndiaAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.5.7. South Korea
- 4.5.7.1. South KoreaAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.5.8. South-East Asia
- 4.5.8.1. South-East AsiaAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.5.9. Rest of Asia Pacific
- 4.5.9.1. Rest of Asia PacificAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.5.1. Asia PacificAdiponectin Testing Market, 2016 – 2026(USD Million)
- 4.6. Latin America
- 4.6.1. Latin AmericaAdiponectin Testing Market, 2016 – 2026(USD Million)
- 4.6.1.1. Latin AmericaAdiponectin Testing Market, by Country, 2016 - 2026(USD Million)
- 4.6.2. Latin AmericaAdiponectin Testing Market, by Type, 2016 – 2026
- 4.6.2.1. Latin AmericaAdiponectin Testing Market, by Type, 2016 – 2026(USD Million)
- 4.6.3. Latin AmericaAdiponectin Testing Market, by Application, 2016 – 2026
- 4.6.3.1. Latin AmericaAdiponectin Testing Market, by Application, 2016 – 2026(USD Million)
- 4.6.4. Brazil
- 4.6.4.1. BrazilAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.6.5. Mexico
- 4.6.5.1. MexicoAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.6.6. Rest of Latin America
- 4.6.6.1. Rest of Latin AmericaAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.6.1. Latin AmericaAdiponectin Testing Market, 2016 – 2026(USD Million)
- 4.7. The Middle-East and Africa
- 4.7.1. The Middle-East and AfricaAdiponectin Testing Market, 2016 – 2026(USD Million)
- 4.7.1.1. The Middle-East and AfricaAdiponectin Testing Market, by Country, 2016 - 2026(USD Million)
- 4.7.2. The Middle-East and AfricaAdiponectin Testing Market, by Type, 2016 – 2026
- 4.7.2.1. The Middle-East and AfricaAdiponectin Testing Market, by Type, 2016 – 2026(USD Million)
- 4.7.3. The Middle-East and AfricaAdiponectin Testing Market, by Application, 2016 – 2026
- 4.7.3.1. The Middle-East and AfricaAdiponectin Testing Market, by Application, 2016 – 2026(USD Million)
- 4.7.4. GCC Countries
- 4.7.4.1. GCC CountriesAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.7.5. South Africa
- 4.7.5.1. South AfricaAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.7.6. Rest of Middle-East Africa
- 4.7.6.1. Rest of Middle-East AfricaAdiponectin TestingMarket, 2016 – 2026(USD Million)
- 4.7.1. The Middle-East and AfricaAdiponectin Testing Market, 2016 – 2026(USD Million)
- Chapter 5 Adiponectin TestingMarket – Competitive Landscape
- 5.1. Competitor Market Share – Revenue
- 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
- 5.3. Strategic Developments
- 5.3.1. Acquisitions and Mergers
- 5.3.2. New Products
- 5.3.3. Research & Development Activities
- Chapter 6 Company Profiles
- 6.1. Stratec SE
- 6.1.1. Company Overview
- 6.1.2. Product/ServicePortfulio
- 6.1.3. Stratec SE Sales, Revenue, and Gross Margin
- 6.1.4. Stratec SE Revenue and Growth Rate
- 6.1.5. Stratec SE Market Share
- 6.1.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
- 6.2. Bio-Rad laboratories
- 6.2.1. Company Overview
- 6.2.2. Product/ServicePortfulio
- 6.2.3. Bio-Rad laboratories Sales, Revenue, and Gross Margin
- 6.2.4. Bio-Rad laboratories Revenue and Growth Rate
- 6.2.5. Bio-Rad laboratories Market Share
- 6.2.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
- 6.3. Thermo Fisher Scientific Inc.
- 6.3.1. Company Overview
- 6.3.2. Product/ServicePortfulio
- 6.3.3. Thermo Fisher Scientific Inc. Sales, Revenue, and Gross Margin
- 6.3.4. Thermo Fisher Scientific Inc. Revenue and Growth Rate
- 6.3.5. Thermo Fisher Scientific Inc. Market Share
- 6.3.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
- 6.4. Merck KGaA
- 6.4.1. Company Overview
- 6.4.2. Product/ServicePortfulio
- 6.4.3. Merck KGaA Sales, Revenue, and Gross Margin
- 6.4.4. Merck KGaA Revenue and Growth Rate
- 6.4.5. Merck KGaA Market Share
- 6.4.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
- 6.5. Eagle Biosciences
- 6.5.1. Company Overview
- 6.5.2. Product/ServicePortfulio
- 6.5.3. Eagle Biosciences Sales, Revenue, and Gross Margin
- 6.5.4. Eagle Biosciences Revenue and Growth Rate
- 6.5.5. Eagle Biosciences Market Share
- 6.5.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
- 6.6. Boster Biulogical Technulogy
- 6.6.1. Company Overview
- 6.6.2. Product/ServicePortfulio
- 6.6.3. Boster Biulogical Technulogy Sales, Revenue, and Gross Margin
- 6.6.4. Boster Biulogical Technulogy Revenue and Growth Rate
- 6.6.5. Boster Biulogical Technulogy Market Share
- 6.6.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
- 6.7. LabCorp
- 6.7.1. Company Overview
- 6.7.2. Product/ServicePortfulio
- 6.7.3. LabCorp Sales, Revenue, and Gross Margin
- 6.7.4. LabCorp Revenue and Growth Rate
- 6.7.5. LabCorp Market Share
- 6.7.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
- 6.1. Stratec SE
- Chapter 7 Adiponectin Testing — Industry Analysis
- 7.1. Introduction and Taxonomy
- 7.2. Adiponectin Testing Market – Key Trends
- 7.2.1. Market Drivers
- 7.2.2. Market Restraints
- 7.2.3. Market Opportunities
- 7.3. Value Chain Analysis
- 7.4. Key Mandates and Regulations
- 7.5. Technulogy Roadmap and Timeline
- 7.6. Adiponectin TestingMarket – Attractiveness Analysis
- 7.6.1. By Type
- 7.6.2. By Application
- 7.6.3. By Region
- Chapter 8 Industrial Chain, Sourcing Strategy, and Downstream Buyers
- 8.1. Adiponectin Testing Industrial Chain Analysis
- 8.2. Downstream Buyers
- 8.3. Distributors/Traders List
- Chapter 9 Marketing Strategy Analysis
- 9.1. Marketing Channel
- 9.2. Direct Marketing
- 9.3. Indirect Marketing
- 9.4. Marketing Channel Development Trends
- 9.5. Economic/Pulitical Environmental Change
- Chapter 10 Report Conclusion& Key Insights
- 10.1. Key Insights from Primary Interviews & Surveys Respondents
- 10.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
- Chapter 11 Research Approach & Methodulogy
- 11.1. Report Description
- 11.2. Research Scope
- 11.3. Research Methodulogy
- 11.3.1. Secondary Research
- 11.3.2. Primary Research
- 11.3.3. Statistical Models
- 11.3.3.1. Company Share Analysis Model
- 11.3.3.2. Revenue Based Modeling
- 11.3.4. Research Limitations
Inquiry For Buying
Adiponectin Testing
Request Sample
Adiponectin Testing
